{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:29:19Z","timestamp":1778286559763,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clnesp.2024.10.167","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T17:36:31Z","timestamp":1730568991000},"page":"425-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Metabolic biomarkers of appetite control in Parkinson's disease patients with and without cognitive impairment"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-0944","authenticated-orcid":false,"given":"Mario","family":"Siervo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fionnuala","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Calton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blossom C.M.","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda K.E.","family":"Hornsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Burn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2024.10.167_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clnesp.2024.10.167_bib2","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.clnesp.2024.10.167_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.archger.2011.06.022","article-title":"Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD)","volume":"55","author":"Kim","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.clnesp.2024.10.167_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.22466","article-title":"Weight loss, body fat mass, and leptin in Parkinson's disease","volume":"24","author":"Loref\u00e4lt","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.clnesp.2024.10.167_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/mds.20837","article-title":"Predictors of weight loss in Parkinson's disease","volume":"21","author":"Uc","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.clnesp.2024.10.167_bib6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.parkreldis.2012.05.004","article-title":"Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes","volume":"18","author":"Sharma","year":"2012","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.clnesp.2024.10.167_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.clnesp.2024.10.167_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/cs0830199","article-title":"Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity","volume":"83","author":"Markus","year":"1992","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.clnesp.2024.10.167_bib9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/bmj.301.6763.1256","article-title":"Increased energy expenditure in Parkinson's disease","volume":"301","author":"Levi","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.clnesp.2024.10.167_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/1028415X.2020.1745427","article-title":"Resting energy expenditure in Parkinson's disease patients under dopaminergic treatment","volume":"25","author":"Barichella","year":"2022","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.clnesp.2024.10.167_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.48.1.88","article-title":"Free-living daily energy expenditure in patients with Parkinson's disease","volume":"48","author":"Toth","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clnesp.2024.10.167_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nn1656","article-title":"Ghrelin controls hippocampal spine synapse density and memory performance","volume":"9","author":"Diano","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.clnesp.2024.10.167_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2024.10.167_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.coph.2007.10.006","article-title":"Leptin regulation of neuronal excitability and cognitive function","volume":"7","author":"Harvey","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1113\/jphysiol.2008.164269","article-title":"The role of peptide YY in appetite regulation and obesity","volume":"587","author":"Karra","year":"2009","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/02699052.2019.1587000","article-title":"GLP-1's role in neuroprotection: a systematic review","volume":"33","author":"Erbil","year":"2019","journal-title":"Brain Inj"},{"key":"10.1016\/j.clnesp.2024.10.167_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040666","article-title":"Research progress on neuroprotection of insulin-like growth factor-1 towards glutamate-induced neurotoxicity","volume":"11","author":"Ge","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clnesp.2024.10.167_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136735","article-title":"Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas","volume":"783","author":"Shi","year":"2022","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clnesp.2024.10.167_bib20","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson's disease symptoms: the patient's perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.clnesp.2024.10.167_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson's disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","article-title":"The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger","volume":"29","author":"Stunkard","year":"1985","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.clnesp.2024.10.167_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.clnesp.2024.10.167_bib24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.clnesp.2024.10.167_bib25","first-page":"228","article-title":"Expanded and independent validation of the movement disorder society-unified Parkinson's disease rating scale (MDS-UPDRS)","volume":"260","author":"Martinez-Martin","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J\u00a0Diabetes Investig."},{"key":"10.1016\/j.clnesp.2024.10.167_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5009\/gnl.2012.6.1.10","article-title":"Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity","volume":"6","author":"De Silva","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.clnesp.2024.10.167_bib28","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0016-5085(85)90211-2","article-title":"Human distribution and release of a putative new gut hormone, peptide YY","volume":"89","author":"Adrian","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2024.10.167_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1538\/expanim.19-0153","article-title":"Electroacupuncture alleviates Parkinson disease and regulates the expression of brain-gut peptides","volume":"69","author":"Yu","year":"2020","journal-title":"Exp Anim"},{"key":"10.1016\/j.clnesp.2024.10.167_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0031-9384(01)00618-7","article-title":"Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1","volume":"74","author":"Hellstr\u00f6m","year":"2001","journal-title":"Physiol Behav"},{"key":"10.1016\/j.clnesp.2024.10.167_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","article-title":"Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?","volume":"54","author":"Nauck","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2024.10.167_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ijcp.12361","article-title":"GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?","volume":"68","author":"Brunton","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clnesp.2024.10.167_bib33","first-page":"277","article-title":"Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease","volume":"16","author":"Alagiakrishnan","year":"2013","journal-title":"Discov Med"},{"key":"10.1016\/j.clnesp.2024.10.167_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early Parkinson's disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnesp.2024.10.167_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bph.15638","article-title":"Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment","volume":"179","author":"Trapp","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2024.10.167_bib37","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnesp.2024.10.167_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227238","article-title":"Clinical correlates of sarcopenia and falls in Parkinson's disease","volume":"15","author":"Lima","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2024.10.167_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.00105","article-title":"Dietary intake of Parkinson's disease patients","volume":"7","author":"Baert","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2024.10.167_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/147683010X12611460763760","article-title":"Controlled-protein dietary regimens for Parkinson's disease","volume":"13","author":"Cereda","year":"2010","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.clnesp.2024.10.167_bib41","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/advances\/nmab060","article-title":"Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson's disease: a systematic review","volume":"12","author":"Boelens Keun","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.clnesp.2024.10.167_bib42","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/nu14214472","article-title":"The role of diet and dietary patterns in Parkinson's disease","volume":"14","author":"Knight","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.10.167_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19148718","article-title":"Protein intake and sarcopenia in older adults: a systematic review and meta-analysis","volume":"19","author":"Coelho-Junior","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.clnesp.2024.10.167_bib44","first-page":"2764","article-title":"Protein intake, nitrogen balance and nutritional status in patients with Parkinson's disease; time for a change?","volume":"31","author":"Zilli Canedo Silva","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnesp.2024.10.167_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.ijo.0801083","article-title":"Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies","volume":"24","author":"Flint","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.clnesp.2024.10.167_bib46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/mds.22372","article-title":"Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients","volume":"24","author":"Delikanaki-Skaribas","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.clnesp.2024.10.167_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410390113","article-title":"Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study","volume":"39","author":"Logroscino","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.copbio.2021.02.007","article-title":"Overview of dietary assessment methods for measuring intakes of foods, beverages, and dietary supplements in research studies","volume":"70","author":"Bailey","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.clnesp.2024.10.167_bib49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ajcn\/76.6.1207","article-title":"Portion size of food affects energy intake in normal-weight and overweight men and women","volume":"76","author":"Rolls","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2024.10.167_bib50","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson's disease","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Parkinsonism Relat Disorders"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724015055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:45:18Z","timestamp":1733143518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724015055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"alternative-id":["S2405457724015055"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.10.167","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic biomarkers of appetite control in Parkinson's disease patients with and without cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.10.167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}